Summary of eligibility criteria and lung cancer detection rates for other screening studies3 7 10 11 15–23
Study | Recruitment period | Recruitment criteria | Screening methods | Cancer detection rate (%) |
---|---|---|---|---|
RCT | ||||
NSLT | 2002–2004 | Age 55–74, ≥30 PY, quit<15 years ago | Annual LDCT or CXR for 3 years | 1.0 |
MILD | 2005–2011 | Age>49, ≥20 PY, quit<10 years ago, no recent cancer within last 5 years | Three groups- no screen vs annual LDCT vs biennial LDCT for 5 years | 0.7 |
ITALUNG | 2004–2006 | Age 55–69, ≥20 PY | Annual LDCT for 4 years vs no screen | 1.4 |
DANTE | 2001–2006 | Age 60–75, ≥20 PY, quit<10 years ago, male | Annual LDCT for 4 years vs no screen | 2.2 |
DLCST | 2004–2006 | Age 50–70, ≥20 PY, quit<10 years ago, FEV1>30%, able to climb two flights of stairs without pausing | Annual LDCT vs usual care for 5 years | 0.8 |
NELSON | 2003–2006 | Age 50–75, ≥15 PY | Annual LDCT for 4 years vs no screen | 0.9 |
UKLS | 2011–2014 | Age 50–75, ≥5% 5-year lung cancer risk as calculated by LLPv2 score | Wald single LDCT screen vs no screen | 2.1 |
Non-RCT | ||||
I-ELCAP | 1993–2006 | Age>60, ≥10 PY | Annual LDCT+CXR for 5 years | 1.3 |
Mayo LDCT trial | 1999 | Age>50, ≥20 PY, quit<10 years ago | Annual LDCT for 5 years | 1.4 |
PANCAN | 2008–2011 | Age 50–75, ≥2% 3-year lung cancer risk as calculated by PLCO score | Annual LDCT for 3 years | 5.5 5-year rate |
COSMOS | 2000–2001 | Age>50, ≥20 PY | Annual LDCT for 10 years | 1.2 |
LUSI | 2007–2011 | Age 50–69, ‘heavy’ smoking history | Annual LDCT+smoking cessation for 5 years vs smoking cessation alone | 1.1 |
COSMOS, Continuing Observation of Smoking Subjects; CXR, Chest X-ray; DLCST, Danish Lung Cancer Screening Project; DANTE, Detection and Screening of Early Lung Cancer by Novel Imaging Technology and Molecular Essays; I-ELCAP, International Early Lung Cancer Action Project; LDCT, low radiation dose CT screening; LLP, Liverpool lung project; LUSI, Lung Cancer Screening Intervention Study; MILD, Multi-centric Italian Lung Detection Trial; NLST, National Lung Screening Trial; PY, pack years; PANCAN, Pan-Canadian Early Detection of Lung Cancer Study; PLCO score, Prostate Lung Colorectal and Ovarian study derived scoring algorithm; RCT, Randomised controlled trial; UKLS, UK Lung Cancer Pilot Screening Trial.